Menopausal Estrogen Replacement Therapy and Breast Cancer

Archives of Internal Medicine

Volumn 151, Issue 1, 1991, Pages 67-72

  Dupont, William D ^a   Page, David L ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; MENOPAUSE; PRIORITY JOURNAL;

BREAST DISEASES; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMAN; MENOPAUSE; META-ANALYSIS; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026034365     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1991.00400010089011     Document Type: Article

References (63)

1. Council on Scientific Affairs. Estrogen replacement in the menopause. JAMA. 1983;249:359-361.
2. Bush TL, Barrett-Connor E. Noncontraceptive estrogen use and cardio vascular disease. Epidemiol Rev. 1985;7:80-104.
3. Kelsey JL, Berkowitz GS. Breast cancer epidemiology. Cancer Res. 1988;48:5615-5623.
4. Mack TM, Henderson BE, Gerkins VR, Arthur M, Baptista J, Pike MC. Reserpine and breast cancer in a retirement community. N Engl J Med. 1975;292:1366-1371.
5. Hoover R, Gray LA Sr, Cole P, MacMahon B. Menopausal estrogens and breast cancer. N Engl J Med. 1976;295:401-405.
6. Casagrande J, Gerkins V, Henderson BE, Mack T, Pike MC. Brief communication: exogenous estrogens and breast cancer in women with natural menopause. J Natl Cancer Inst. 1976;56:839-841.
7. Byrd BF Jr, Burch JC, Vaughn WK. The impact of long term estrogen support after hysterectomy. Ann Surg. 1977;185:574-579.
8. Wynder EL, MacCornack FA, Stellman SD. The epidemiology of breast cancer in 785 United States Caucasian women. Cancer. 1978;41:2341-2354.
9. Ravnihar B, Seigel DG, Lindtner J. An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. Eur J Cancer Clin Oncol. 1979;15:395-405.
10. Jick H, Walker AM, Watkins RN, et al. Replacement estrogens and breast cancer. Am J Epidemiol. 1980;112:586-594.
11. Ross RK, Paganini-Hill A, Gerkins VR, et al. A case-control study of menopausal estrogen therapy and breast cancer. JAMA. 1980;243:1635-1639.
12. Hoover R, Glass A, Finkle WD, Azevedo D, Milne K. Conjugated estrogens and breast cancer risk in women. J Natl Cancer Inst. 1981;67:815-820.
13. Kelsey JL, Fischer DB, Holford TR, et al. Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst. 1981;67:327-333.
14. Thomas DB, Persing JP, Hutchinson WB. Exogenous estrogens and other risk factors for breast cancer in women with benign breast disease. J Natl Cancer Inst. 1982;69:1017-1025.
15. Hulka BS, Chambless LE, Deubner DC, Wilkinson WE. Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol. 1982;143:638-644.
16. Vakil DV, Morgan RW, Halliday M. Exogenous estrogens and develop ment of breast and endometrial cancer. Cancer Detect Prev. 1983;6:415-424.
17. Gambrell RD Jr, Maier RC, Sanders BI. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol. 1983;62:435-443.
18. Sherman B, Wallace R, Bean J. Estrogen use and breast cancer: interac tion with body mass. Cancer. 1983;51:1527-1531.
19. Kaufman DW, Miller DR, Rosenberg L, et al. Noncontraceptive estro gen use and the risk of breast cancer. JAMA. 1984;252:63-67.
20. Horwitz RI, Stewart KR. Effect of clinical features on the association of estrogens and breast cancer. Am J Med. 1984;76:192-198.
21. Hiatt RA, Bawol R, Friedman GD, Hoover R. Exogenous estrogen and breast cancer after bilateral oophorectomy. Cancer. 1984;54:139-144.
22. Nomura AMY, Kolonel LN, Hirohata T, Lee J. The association of replacement estrogens with breast cancer. Int J Cancer. 1986;37:49-53.
23. McDonald JA, Weiss NS, Daling JR, Francis AM, Polissar L. Menopaus al estrogen use and the risk of breast cancer. Breast Cancer Res Treat. 1986;7:193-199.
24. Brinton LA, Hoover R, Fraumeni JF Jr. Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br J Cancer. 1986;54:825-832.
25. Buring JE, Hennekens CH, Lipnick RJ, et al. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. Am J Epidemiol. 1987;125:939-947.
26. Wingo PA, Layde PM, Lee NC, Rubin G, Ory HW. The risk of breast cancer in postmenopausal women who have used estrogen replacement thera py. JAMA. 1987;257:209-215.
27. Hunt K, Vessey M, McPherson K, Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynecol. 1987;94:620-635.
28. Rohan TE, McMichael AJ. Non-contraceptive exogenous oestrogen therapy and breast cancer. Med J Aust. 1988;148:217-221.
29. Dupont WD, Page DL, Rogers LW, Parl FF. Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer. 1989;63:948-957.
30. Mills PK, Beeson WL, Phillips RL, Fraser GE. Prospective study of exogenous hormone use and breast cancer in Seventh-Day Adventists. Cancer. 1989;64:591-597.
31. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989;321:293-297.
32. Boston Collaborative Drug Surveillance Program. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. N Engl J Med. 1974;290:15-19.
33. Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy, II: neoplasia. Am J Obstet Gynecol. 1979;133:537-547.
34. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy, II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol. 1979;54:74-79.
35. Wallach S, Henneman PH. Prolonged estrogen therapy in postmeno pausal women. JAMA. 1959;171:1637-1642.
36. Wilson RA. The roles of estrogen and progesterone in breast and genital cancer. JAMA. 1962;182:327-331.
37. Mustacchi P, Gordon GS. Frequency of cancer in estrogen-treated osteoporotic women. In: Segaloff A, ed. Breast Cancer: The Second Biennial Louisi ana Cancer Conference, New Orleans, Jan. 22-23, 1958. St Louis, Mo: CV Mosby Co; 1958:163-169.
38. Brinton LA, Williams RR, Hoover RN, Stegens NL, Feinleib M, Fraumeni JF Jr. Breast cancer risk factors among screening program participants. J Natl Cancer Inst. 1979;62:37-44.
39. Brinton LA, Hoover RN, Szklo M, Fraumeni JF Jr. Menopausal estro gen use and risk of breast cancer. Cancer. 1981;47:2517-2522.
40. Bland KI, Buchanan JB, Weisberg BF, Hagan TA, Gray LA Sr. The effects of exogenous estrogen replacement therapy of the breast: breast cancer risk and mammographic parenchymal patterns. Cancer. 1980;45:3027-3033.
41. Gambrell RD, Massey FM, Castaneda TA, Boddie AW. Estrogen thera py and breast cancer in postmenopausal women. J Am Geriatr Soc. 1980;28:251-257.
42. Gambrell RD. Role of hormones in the etiology and prevention of endometrial and breast cancer. Acta Obstet Gynecol Scand Suppl. 1982;106:37-46.
43. Gambrell RD Jr. Hormones in the etiology and prevention of breast and endometrial cancer. South Med J. 1984;77:1509-1515.
44. Nomura AM, Hirohata T, Kolonel LN, Hankin JH, Lee J, Stemmermann G. Breast cancer in Caucasian and Japanese women in Hawaii. Natl Cancer Inst Monogr. 1985;69:191-196.
45. Burch JC, Byrd BF Jr, Vaughn WK. The effects of long-term estrogen on hysterectomized women. Am J Obstet Gynecol. 1974;118:778-782.
46. Byrd BF Jr, Burch JC, Vaughn WK. Significance of postoperative estrogen therapy on the occurrence and clinical course of cancer. Ann Surg. 1973;177:626-631.
47. Burch JC, Byrd BF Jr. Effects of long-term administration of estrogen on the occurrence of mammary cancer in women. Ann Surg. 1971;174:414-418.
48. Henderson BE, Powell D, Rosario I, et al. An epidemiologic study of breast cancer. J Natl Cancer Inst. 1974;53:609-614.
49. Arthes FG, Sartwell PE, Lewison EF. The pill, estrogens, and the breast. Cancer. 1971;28:1391-1394.
50. Lawson DH, Jick H, Hunter JR, Madsen S. Exogenous estrogens and breast cancer. Am J Epidemiol. 1981;114:710-713.
51. Sartwell PE, Arthes FG, Tonascia JA. Exogenous hormones, reproduc tive history, and breast cancer. J Natl Cancer Inst. 1977;59:1589-1592.
52. LaVecchia C, DeCarli A, Parazzini F, Gentile A, Liberati C, Franceschi S. Non-contraceptive oestrogens and the risk of breast cancer in women. Br J Cancer. 1986;38:853-858.
53. Craig TJ, Comstock GW, Geiser PB. Epidemiologic comparison of breast cancer patients with early and late onset of malignancy and general population controls. J Natl Cancer Inst. 1974;53:1577-1581.
54. Dupont WD, Page DL. Letter to the editor. Cancer. 1990;65:1261-1262.
55. Dupont WD, Page DL. L’oestrogenotherapie substitutive accroit-elle le risque de cancer du sein? Contracept Fertil Sex. 1990;18:115-119.
56. Feinglos SJ. MEDLINE: A Basic Guide to Searching. Chicago, Ill: Medical Library Association; 1985.
57. Greenland S. Quantitative methods in the review of epidemiologic litera ture. Epidemiol Rev. 1987;9:1-30.
58. Breslow NE, Day NE. Statistical Methods in Cancer Research. Lyon, France: IARC Scientific Publications; 1980:134, 146-152.
59. Rao CR. Linear Statistical Inference and Its Applications. 2nd ed. New York, NY: John Wiley & Sons Inc; 1973:426.
60. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc. 1963;58:690-700.
61. Key TJA, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988;24:29-43.
62. Anderson TJ, Ferguson DJP, Raab GM. Cell turnover in the ‘resting’ human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer. 1982;46:376-382.
63. Kennedy DL, Baum C, Forbes MB. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol. 1985;65:441-446.